Market Closed -
TEL AVIV STOCK EXCHANGE
07:24:08 2024-04-25 am EDT
|
5-day change
|
1st Jan Change
|
999.9
ILa
|
+0.77%
|
|
+5.81%
|
+115.91%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
28.9
|
417.5
|
404.1
|
440.5
|
932.3
|
550.5
|
Enterprise Value (EV)
2 |
29.05
|
426.6
|
393.6
|
407.6
|
844.6
|
572.9
|
P/E ratio
|
-18.3
x
|
-31.6
x
|
-124
x
|
-11.2
x
|
207
x
|
12.2
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
45,271,664
x
|
6,773,655
x
|
4,243,845
x
|
1,416,365
x
|
EV / Revenue
|
-
|
-
|
44,099,358
x
|
6,268,065
x
|
3,844,919
x
|
1,473,908
x
|
EV / EBITDA
|
-92.5
x
|
-42.1
x
|
-4.96
x
|
286
x
|
23.8
x
|
11.9
x
|
EV / FCF
|
-52.9
x
|
161
x
|
-18.4
x
|
-33
x
|
116
x
|
-12.3
x
|
FCF Yield
|
-1.89%
|
0.62%
|
-5.44%
|
-3.03%
|
0.86%
|
-8.16%
|
Price to Book
|
4.86
x
|
21.2
x
|
1.58
x
|
1.6
x
|
2.09
x
|
1.1
x
|
Nbr of stocks (in thousands)
|
17,558
|
18,548
|
24,382
|
26,942
|
44,994
|
45,573
|
Reference price
3 |
1.646
|
22.51
|
16.57
|
16.35
|
20.72
|
12.08
|
Announcement Date
|
3/26/18
|
4/1/19
|
4/30/20
|
3/31/21
|
4/5/22
|
3/31/23
|
1ILS in Million2USD in Million3ILS Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
|
-
|
-
|
8.926
|
65.04
|
219.7
|
388.7
|
EBITDA
1 |
-0.314
|
-10.12
|
-79.4
|
1.425
|
35.53
|
48.34
|
EBIT
1 |
-0.315
|
-10.13
|
-79.98
|
-1.205
|
30.41
|
40.85
|
Operating Margin
|
-
|
-
|
-896.06%
|
-1.85%
|
13.84%
|
10.51%
|
Earnings before Tax (EBT)
1 |
-1.513
|
-12.8
|
-3.669
|
-38.31
|
18.74
|
43.84
|
Net income
1 |
-1.513
|
-12.8
|
-2.996
|
-37.23
|
4.692
|
44.82
|
Net margin
|
-
|
-
|
-33.56%
|
-57.25%
|
2.14%
|
11.53%
|
EPS
2 |
-0.0902
|
-0.7125
|
-0.1335
|
-1.466
|
0.1000
|
0.9882
|
Free Cash Flow
1 |
-0.5489
|
2.649
|
-21.4
|
-12.36
|
7.275
|
-46.73
|
FCF margin
|
-
|
-
|
-239.8%
|
-19%
|
3.31%
|
-12.02%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
20.48%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
155.04%
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/26/18
|
4/1/19
|
4/30/20
|
3/31/21
|
4/5/22
|
3/31/23
|
Fiscal Period: December |
2021 Q1
|
2021 Q2
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
---|
Net sales
1 |
10.06
|
14.02
|
19.89
|
26.39
|
25.71
|
29.28
|
29.5
|
29.42
|
28.99
|
26.94
|
EBITDA
1 |
-
|
-
|
-
|
7.197
|
6.278
|
6.796
|
5.764
|
5.161
|
-
|
2.988
|
EBIT
1 |
1.709
|
2.541
|
2.308
|
2.831
|
4.924
|
4.835
|
4.12
|
2.271
|
1.841
|
1.321
|
Operating Margin
|
16.99%
|
18.13%
|
11.6%
|
10.73%
|
19.15%
|
16.51%
|
13.96%
|
7.72%
|
6.35%
|
4.9%
|
Earnings before Tax (EBT)
1 |
1.529
|
2.627
|
0.6695
|
0.7974
|
5.72
|
6.475
|
3.504
|
-2.43
|
0.4844
|
0.106
|
Net income
1 |
0.7951
|
1.919
|
-0.53
|
-0.9567
|
3.942
|
4.689
|
2.128
|
2.382
|
0.0584
|
1.284
|
Net margin
|
7.91%
|
13.69%
|
-2.66%
|
-3.63%
|
15.33%
|
16.01%
|
7.21%
|
8.1%
|
0.2%
|
4.77%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/17/21
|
8/16/21
|
11/15/21
|
4/4/22
|
5/16/22
|
8/15/22
|
11/15/22
|
3/31/23
|
5/15/23
|
8/31/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
0.14
|
9.12
|
-
|
-
|
-
|
22.4
|
Net Cash position
1 |
-
|
-
|
10.5
|
32.9
|
87.6
|
-
|
Leverage (Debt/EBITDA)
|
-0.4522
x
|
-0.9003
x
|
-
|
-
|
-
|
0.4627
x
|
Free Cash Flow
1 |
-0.55
|
2.65
|
-21.4
|
-12.4
|
7.27
|
-46.7
|
ROE (net income / shareholders' equity)
|
-24.8%
|
-61.9%
|
-2.17%
|
-13.1%
|
1.94%
|
8.83%
|
ROA (Net income/ Total Assets)
|
-2.79%
|
-20.7%
|
-31.4%
|
-0.25%
|
3.75%
|
3.09%
|
Assets
1 |
54.18
|
61.7
|
9.534
|
15,043
|
125
|
1,452
|
Book Value Per Share
2 |
0.3400
|
1.060
|
10.50
|
10.20
|
9.930
|
11.00
|
Cash Flow per Share
2 |
0.0300
|
0.1800
|
1.120
|
1.410
|
4.350
|
5.100
|
Capex
|
-
|
0.09
|
28.1
|
20.8
|
14
|
19.7
|
Capex / Sales
|
-
|
-
|
315.3%
|
32.05%
|
6.39%
|
5.08%
|
Announcement Date
|
3/26/18
|
4/1/19
|
4/30/20
|
3/31/21
|
4/5/22
|
3/31/23
|
|
1st Jan change
|
Capi.
|
---|
| +115.91% | 119M | | +27.84% | 272M | | +37.04% | 261M | | +47.67% | 194M | | +44.50% | 131M | | -28.57% | 121M | | -39.80% | 119M | | +3.85% | 86.82M | | +150.00% | 75.33M | | +3.61% | 55.24M |
Medical Farming
|